SEC Filing Details

SEC Filing Details

Document Details

Form
3
Filing Date
Sep 28, 2022
Document Date
Sep 19, 2022
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.
Filer
WEISS ASSET MANAGEMENT LP

©2019- Theravance Biopharma.  All rights reserved.  Terms of Use.  Privacy Policy.  Social Media Guidelines.

THERAVANCE BIOPHARMA®, THERAVANCE®, the Cross/Star logo and MEDICINES THAT MAKE A DIFFERENCE®, are registered trademarks, and TARGETING WHAT MATTERS MOST™ is a trademark of the Theravance Biopharma group of companies (in the U.S. and certain other countries). YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris Company. Trademarks, trade names or service marks of other companies appearing on this website are the property of their respective owners.